Correction to: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2025), 31, 1, (126-136), 10.1038/s41591-024-03282-2)

Jing Pan; Yue Tan; Lingling Shan; Samuel Seery; Biping Deng; Zhuojun Ling; Jinlong Xu; Jiajia Duan; Zelin Wang; Kai Wang; Xinjian Yu; Qinlong Zheng; Xiuwen Xu; Guang Hu; Taochao Tan; Ying Yuan; Zhenglong Tian; Fangrong Yan; Yajing Han; Jiecheng Zhang; Xiaoming Feng

doi:10.1038/s41591-024-03348-1

Correction to: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2025), 31, 1, (126-136), 10.1038/s41591-024-03282-2)

Jing Pan
, Yue Tan
, Lingling Shan
, Samuel Seery
, Biping Deng
, Zhuojun Ling
, Jinlong Xu
, Jiajia Duan
, Zelin Wang
, Kai Wang
, Xinjian Yu
, Qinlong Zheng
, Xiuwen Xu
, Guang Hu
, Taochao Tan
, Ying Yuan
, Zhenglong Tian
, Fangrong Yan
, Yajing Han
, Jiecheng Zhang

Xiaoming Feng

Biostatistics

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03282-2, published online 1 October 2024. In the version of the article initially published, in Table 1, the “EO14” row was included in cohort B when it should have been part of cohort A. The amended table can now be found in the HTML and PDF versions of the article.

Original language	English (US)
Pages (from-to)	352
Number of pages	1
Journal	Nature medicine
Volume	31
Issue number	1
DOIs	https://doi.org/10.1038/s41591-024-03348-1
State	Published - Jan 2025

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/s41591-024-03348-1

Cite this

Pan, J., Tan, Y., Shan, L., Seery, S., Deng, B., Ling, Z., Xu, J., Duan, J., Wang, Z., Wang, K., Yu, X., Zheng, Q., Xu, X., Hu, G., Tan, T., Yuan, Y., Tian, Z., Yan, F., Han, Y., ... Feng, X. (2025). Correction to: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2025), 31, 1, (126-136), 10.1038/s41591-024-03282-2). Nature medicine, 31(1), 352. https://doi.org/10.1038/s41591-024-03348-1

Pan, J, Tan, Y, Shan, L, Seery, S, Deng, B, Ling, Z, Xu, J, Duan, J, Wang, Z, Wang, K, Yu, X, Zheng, Q, Xu, X, Hu, G, Tan, T, Yuan, Y, Tian, Z, Yan, F, Han, Y, Zhang, J & Feng, X 2025, 'Correction to: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2025), 31, 1, (126-136), 10.1038/s41591-024-03282-2)', Nature medicine, vol. 31, no. 1, pp. 352. https://doi.org/10.1038/s41591-024-03348-1

@article{a605a195e52d4e7ab51b85174c796378,

title = "Correction to: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2025), 31, 1, (126-136), 10.1038/s41591-024-03282-2)",

abstract = "Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03282-2, published online 1 October 2024. In the version of the article initially published, in Table 1, the {\textquotedblleft}EO14{\textquotedblright} row was included in cohort B when it should have been part of cohort A. The amended table can now be found in the HTML and PDF versions of the article.",

author = "Jing Pan and Yue Tan and Lingling Shan and Samuel Seery and Biping Deng and Zhuojun Ling and Jinlong Xu and Jiajia Duan and Zelin Wang and Kai Wang and Xinjian Yu and Qinlong Zheng and Xiuwen Xu and Guang Hu and Taochao Tan and Ying Yuan and Zhenglong Tian and Fangrong Yan and Yajing Han and Jiecheng Zhang and Xiaoming Feng",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature America, Inc. 2024.",

year = "2025",

month = jan,

doi = "10.1038/s41591-024-03348-1",

language = "English (US)",

volume = "31",

pages = "352",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2025), 31, 1, (126-136), 10.1038/s41591-024-03282-2)

AU - Pan, Jing

AU - Tan, Yue

AU - Shan, Lingling

AU - Seery, Samuel

AU - Deng, Biping

AU - Ling, Zhuojun

AU - Xu, Jinlong

AU - Duan, Jiajia

AU - Wang, Zelin

AU - Wang, Kai

AU - Yu, Xinjian

AU - Zheng, Qinlong

AU - Xu, Xiuwen

AU - Hu, Guang

AU - Tan, Taochao

AU - Yuan, Ying

AU - Tian, Zhenglong

AU - Yan, Fangrong

AU - Han, Yajing

AU - Zhang, Jiecheng

AU - Feng, Xiaoming

PY - 2025/1

Y1 - 2025/1

N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03282-2, published online 1 October 2024. In the version of the article initially published, in Table 1, the “EO14” row was included in cohort B when it should have been part of cohort A. The amended table can now be found in the HTML and PDF versions of the article.

AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03282-2, published online 1 October 2024. In the version of the article initially published, in Table 1, the “EO14” row was included in cohort B when it should have been part of cohort A. The amended table can now be found in the HTML and PDF versions of the article.

UR - https://www.scopus.com/pages/publications/85207318191

UR - https://www.scopus.com/pages/publications/85207318191#tab=citedBy

U2 - 10.1038/s41591-024-03348-1

DO - 10.1038/s41591-024-03348-1

M3 - Comment/debate

C2 - 39415025

AN - SCOPUS:85207318191

SN - 1078-8956

VL - 31

SP - 352

JO - Nature medicine

JF - Nature medicine

IS - 1

ER -

Correction to: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2025), 31, 1, (126-136), 10.1038/s41591-024-03282-2)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this